Response and Resistance to NF-κB Inhibitors in Mouse Models of Lung Adenocarcinoma
Lung adenocarcinoma is a leading cause of cancer death worldwide. We recently showed that genetic inhibition of the NF-κB pathway affects both the initiation and the maintenance of lung cancer, identifying this pathway as a promising therapeutic target. In this investigation, we tested the efficacy...
| Main Authors: | , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
American Association for Cancer Research
2011
|
| Online Access: | http://hdl.handle.net/1721.1/66545 https://orcid.org/0000-0001-5785-8911 |